Covid-19: Pfizer / BioNTech asks European regulators for vaccine authorization

Pfizer / BioNTech had already placed an order for use of the coronavirus vaccine with US and British regulators.

Pfizer / BioNTech has asked European regulators for authorization for its coronavirus vaccine, as it had already done in the United States (20 November) and Britain, as reported by Reuters.

The vaccine from Pfizer / BioNTech, according to the final results of the tests, showed an efficiency of 95%. Reuters underlines that these results could lead to the vaccine from both companies being available, after authorization from US and European regulators, already in December.

Moderna was another company that had also announced the request, to the European Medicines Agency (EMA), European regulator, for an authorization to use the vaccine against covid-19.

Recommended

Marcelo Rebelo de Sousa admits that the confinement period will last until March

The President of the Republic, Marcelo Rebelo de Sousa, admitted this Friday that the confinement period currently in force in Portugal may extend until March, warning of the importance of flattening the contagion curve.

Dombrovskis: "It is feasible that Portugal could be one of the first countries to have the recovery plan approved"

In an interview with Jornal Económico, the vice-president of the European Commission says that the draft of the Portuguese Recovery Plan “goes in the right direction”, emphasizing that the community executive continues to work with the Government in the component of the plan's reforms.

Dombrovskis: “Portugal is a good example of a country that took advantage of the good times in the economy to lower the debt level”

The Vice-President of the European Commission praises, in an interview with Jornal Económico, the trajectory of the reduction of the public debt to GDP ratio made by Portugal in recent years and underlines the importance of recovery plans. “It is difficult for countries to come out of this crisis alone”, he adds.
Comments